About ACTC: "Just as importantly 17 of 18 showed that the progression has halted. These are blockbuster results. There are more than 30 million Dry AMD patients in North America and Europe alone, with no approved treatments currently available. They have also proven to be 100% safe so far. A safety profile like this is remarkable as well."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.